SHLT earnings

SHL Telemedicine Ltd. (NASDAQ:SHLT, SIX Swiss Exchange: SHLTN))) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, announced today its results for the full-year 2023, highlighting fiscally responsible growth across all regions and a strategic focus on expansion and innovation. In 2023, SHL Telemedicine achieved key highlights, underscoring its global market strength. SHL's Israel operation maintained stability and profitability, reflecting the company's solid foundation in its home market. In the US, significant advancements were made toward launching direct-to-consumer (B2C) sales of the SmartHeart® ECG platform, enhancing access to r

SHL Telemedicine Ltd. ((SIX Swiss Exchange: SHLTN, NASDAQ:SHLT) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, today announced that it will publish its results for 2023 on Wednesday, April 17, 2024 at 7 am CET. The conference call for investors, journalists, and analysts to discuss the annual results 2023 will be hosted by Yariv Alroy, Chairman, Erez Nachtomy, CEO, and Amir Hai, CFO, and has been scheduled for the same day as following: Date: Wednesday, April 17, 2024 Time: 4 pm CET / 10 am ET / 5 pm Israel Time The conference call can be accessed live via the below dial-in numbers: From Europe   +41 (0) 58 310 5

Regulatory News: SHL Telemedicine Ltd. (NASDAQ:SHLT, SIX Swiss Exchange: SHLTN))) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, announced today its results for half-year 2023, emphasizing stable revenues and strategic growth initiatives. In H1 2023, SHL maintained stable revenues while making significant strategic advancements across all operations. The Company made substantial investments in Germany, where it launched the Doctors' Virtual Visits services and then witnessed a steady increase in the adoption of the service. In the US, the Company witnessed the growing utilization and distribution of the SmartHeart® ECG platform by

TEL AVIV, Israel, ZURICH and NEW YORK, Sept. 6, 2023 /PRNewswire/ --  SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (NASDAQ:SHLT) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, today announced that it will issue its Half-year 2023 results before market opens on Thursday, September 21, 2023. The conference call for investors, journalists, and analysts to discuss the half-year results 2023 will be hosted by Erez Nachtomy, CEO, and Amir Hai, CFO, and has been scheduled for: Date: Thursday, 21 September 2023 Time: 4 pm CET / 10 am ET / 5 pm Israel Time The conference call can be accessed live via the dial-in numbers: From Europe